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http://dx.doi.org/10Background and Aims. Quercitrin (QR; quercetin-3-O-rhamnoside) has been used previ-
ously as an antibacterial agent and has been shown to inhibit the oxidation of low-density
lipoproteins and prevent an allergic reaction. Furthermore, it was demonstrated that quer-
citrin exerts protective effects against H2O2-induced dysfunction in lung fibroblast cells.
However, the mechanisms of quercitrin effects on cancer cell proliferation and apoptosis
is not well understood. The aim of this study is to investigate the cytotoxic and apoptotic
effects of quercitrin and the molecular mechanisms of quercitrin-induced apoptosis in
non-small cell lung cancer (NSCLC) cell lines.
Methods. Time- and dose-dependent antiproliferative and apoptotic effects of quercitrin
determined by WST-1 cell proliferation assay, lactate dehydrogenase (LDH) cytotoxicity
assay, determination of nucleosome enrichment factor, changes in caspase-3 activity, loss
of mitochondrial membrane potential (MMP) and also the localization of phosphatidyl-
serine in the plasma membrane. Changes in whole genome gene expression levels were
examined by Illumina Human HT-12v4 beadchip microarrays.
Results. There were significant increases in caspase-3 activity, loss of MMP, and in-
creases in apoptotic cell population in response to quercitrin in A549 and NCI-H358
NSCLC cells in a time- and dose-dependent manner.
Conclusion. Our results demonstrated that genes involved in leukocyte transendothelial
migration, cell adhesion and phosphatidylinositol signaling system pathways were the
most statistically significant pathways in NCI-H358 and A549 cells. These results re-
vealed that quercitrin has antiproliferative and apoptotic effects on lung cancer cells by
modulating the immune response. After confirming its anticarcinogenic effects in vivo,
quercitrin could be a novel and strong anticancer agent against NSCLC.  2014 IMSS.
Published by Elsevier Inc.
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Lung cancer is the leading cause of cancer-related deaths
worldwide among women and men, which is estimated at
O1,000,000 deaths each year (1). Lung cancer is clinically
divided into two classes, non-small cell lung cancerquests to: Dr., Prof., Bedia Cakmakoglu, Istanbul
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.1016/j.arcmed.2014.08.002(NSCLC) and small cell lung cancer (SCLC) due to their
tendency to metastasize and response to existing therapies
(2). NSCLC accounts for 80% of all lung cancer cases, with
adenocarcinoma being the major subtype (3). NSCLC is
less responsive to chemotherapy and as such has been the
main focus of current research on investigating new drugs
for its therapy (4). The prognosis of lung cancer is poor
because of the late diagnosis at advanced stage (5).
Although 70% of newly diagnosed patients present with
locally advanced or metastatic lung cancer and require sys-
temic treatment, chemotherapeutic drugs and molecularInc.
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toxicities and acquisition of drug resistance (6e8). Recent
studies have focused on dietary agents to develop effective
prevention strategies for lung cancer including nutraceuti-
cals, which are non-toxic, cost-effective, and physiologi-
cally bioavailable (9e11).
Flavonoids are widely found in fruits and vegetables and
exert various biological activities that are mainly related to
their abilities to inhibit enzymes, their antioxidant proper-
ties, and to their effects on immune responses (12). These
properties could explain the beneficial effects that flavonoid
intake exerts in different human pathologies including hy-
pertension, inflammatory conditions, and cancer (13). Quer-
citrin is the most abundant bioflavonoid compound, which
is mainly present in the glycoside form (14). The sugar
portion is bound to the aglycone portion in quercitrin that
increases its solubility and improves absorption. Recent
studies demonstrated that quercitrin exhibits a scavenger
and anti-oxidant role; consequently, quercitrin has become
the center of attention for its potential anti-carcinogenic ac-
tivity (15). Although different studies have indicated that
quercitrin is a potent antioxidant, the action of this com-
pound is not well understood (16e18). Hence, we proposed
to investigate whether quercitrin has apoptotic and antipro-
liferative effects in NSCLC and lung fibroblast cells and
examined its effects on genome-wide expression profiling.Materials and Methods
Cell Culture
The bronchioalveolar carcinoma cell line NCI-H358
(ATCC number: CRL-5807) and lung fibroblast cell line
MRC-5 (ATCC number: CCL-171) as a control line were
obtained from the ATCC (American Type Culture Collec-
tion, Manassas, VA). The A549 adenocarcinoma cell line
was kindly provided by Dr. Yusuf Baran (Department of
Molecular Biology and Genetics, IYTE). NCI-H358 cell
line was cultured in an RPMI-1640 medium (ATCC modi-
fication) containing 1% penicillin/streptomycin and 10%
fetal bovine serum at 37C in 5% CO2. The A549 and
MRC-5 cell lines were cultured in MEM-a medium con-
taining 1% penicillin/streptomycin and 10% fetal bovine
serum at 37C in 5% CO2.
Measurement of Cell Growth and Cytotoxicity
To detect effects on cell viability after quercitrin treat-
ment, WST-1 cell proliferation assay performed. The
WST-1 conversion assay (Roche, Germany) is based on
the mitochondrial function of intact cells, which enables
them to metabolize the stable tetrazolium salt WST-1
(4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-
1,3-benzene disulfonate) to a soluble violet formazan prod-
uct. Ninety-six-well plates containing 100 ml of the growthmedium were seeded at 1  104 cells/well in the absence or
presence of increasing concentrations of quercitrin and then
incubated at 37C in 5% CO2 for 24, 48 and 72 h. After the
incubation period, cells were treated with 10 ml of WST-1
for 4 h. Color development was measured at 450 nm using
a Multiscan ELISA reader (Thermo Fisher Scientific,
Germany). Viability was calculated by subtraction of the
mean values without WST-1 from those with WST-1 sub-
strate and expressed as a percentage of control. Data were
confirmed by an additional three independent experiments.
Dose- and time-dependent cytotoxic effects of quercitrin
were colorimetrically determined with a ‘‘CytoTox 96R
Non-Radioactive Cytotoxicity Assay’’ kit from Promega
(Madison, WI). Cells were treated as described for the
WST-1 assay. Culture medium (10 ml) was then transferred
to a 96-well microtiter plate. The levels of lactate dehydro-
genase (LDH) were determined by adding 50 ml freshly pre-
pared Substrate Mix, incubating in darkness at room
temperature for 30 min, adding 50 ml STOP Solution, and
measuring optical density (OD) at 490 nm with a micro-
plate reader (Bio-Rad, Hercules, CA). Data were confirmed
by three further independent experiments.
Detection of Apoptotic Nucleosomes and Necrotic DNA
Release
The Cell Death Detection ELISAPLUS (CDDE) kit is a
photometric enzyme-immunoassay for the qualitative and
quantitative in vitro determination of DNA in the superna-
tant of treated cells that indicates necrosis and cytoplasmic
histone-associated DNA fragments (mono- and oligonu-
cleosomes) indicating apoptosis (Roche, Germany). Appli-
cation according to manufacturer’s instructions provides
concurrent detection of apoptosis and necrosis in the same
well. Color development of samples was considered as an
enrichment factor of the amount of DNA fragments in the
cytoplasm or cell supernatant, indicating apoptosis or ne-
crosis, respectively, and expressed relative to untreated
cells. In order to investigate possible interferences with
the assay, particles were added to the cells in a concentra-
tion two fold higher than the final concentration used in
the above experiment (160 mg/cm2). Subsequently, the sam-
ples were centrifuged (10 min, 200 g) in conformance with
the CDDE kit protocol. The supernatant was then mixed 1:1
with the lysate of 50 mm quercitrin treated cells for 48 and
72 h using a lysis buffer, which is included in the kit, and
analysed according to the manufacturer’s instructions.
Analysis of Phosphatidylserine Exposure and Cell
Permeability
During apoptotic cell death, phosphatidylserine (PS), a
phospholipid component of the inner-leaflet of cell mem-
branes, becomes available at the cell surface. This early
marker of apoptotic cell death can be detected by staining
with the green fluorescent dye Annexin V-FITC (BD
447Quercitrin in Non-Small Cell Lung Cancer CellsPharmingen, Germany), a fluorochrome-conjugated Ca2þ-
dependent PS-binding protein. In combination with the 7-
AAD-DNA-staining, dye exclusion of vital cells permits
discrimination between apoptotic and necrotic cells. Cells
treated in 24-well dishes were centrifuged (200 g, 5 min,
4C), washed with HBSS/ (GIBCO, Germany) and
stained with 150 ml of buffer (10 mmol HEPES/NaOH
pH 7.4, 150 mmol NaCl, 5 mmol KCl, 2 mmol CaCl) con-
taining 5 ml Annexin V-FITC (1 mg/mL) and 1.5 mmol
7-AAD at 37C. After 10 min, an additional 500 ml of
ice-cold buffer was added and cells were harvested by
scraping the ice. After centrifugation (200 g, 5 min, 4C),
cells were suspended in 250 ml buffer and immediately an-
alysed by flow cytometry using the green-collecting fluores-
cent channels FL-1 for Annexin V-FITC and FL-3 for
7-AAD, as described above. Quadrant separation in the
fluorescent channels FL-1 (Annexin V-FITC) vs. FL-3
(7-AAD) represents events of necrotic and late apoptotic
cells, respectively, which are 7-AAD positive (Q1 þ Q2);
apoptotic cells (Q3, Annexin V-FITC positive and 7-AAD
negative) and viable cells (Q4, fluorescent negative)
expressed as percentage of total cells.
Analysis of Caspase-3 Enzyme Activity
Changes in caspase-3 enzyme activity of the cells are an
important sign of apoptosis. These were examined by
caspase-3 colorimetric assay kit (BioVision Research
Products, Milpitas, CA). This assay is based on spectro-
photometric detection of the chromophore p-nitroanilide
(pNA) after cleavage from the labeled substrate DEVD-
pNA, which can be recognized by caspase-3. In short,
the cells (5  105 cells/2 mL/well) induced apoptosis
and were collected by centrifugation at 1000 rpm for
10 min. Cells were lysed by adding 50 ml of chilled cell
lysis buffer and incubated on ice for 10 min before centri-
fugation at 10 000 g for 1 min. Supernatants were trans-
ferred to new Eppendorf tubes, and the reaction mixture
was prepared in 96-well plates by adding 50 ml of reaction
buffer (containing 10 mmol DTT), 50 ml of sample, and
5 ml of DEVD-pNA substrate and incubated for 2 h at
37C in CO2 incubator. After incubation, the plate was
read under 405 nm wavelengths using an ELISA reader
(Thermo Electron Corporation Multiskan Spectrum,
Finland). The absorbance values were normalized to pro-
tein concentrations determined by a Bradford assay, as
described previously.
Determination of Loss in Mitochondrial Membrane
Potential
We examined the loss of MMP, another important sign of
apoptosis, in response to quercitrin treatment for 48 h in
A549 and MRC5 cells by JC-1 Mitochondrial Membrane
Potential Detection Kit (Cayman Chemicals, Ann Arbor,
MI). This kit uses JC-1, a unique cationic dye, to signalthe loss of the MMP. JC-1 accumulates in the mitochondria,
which stain red in nonapoptotic cells, whereas in apoptotic
cells, the MMP collapses; thus, the JC-1 remains in the
cytoplasm as a monomer that stains green under fluorescent
light. In brief, the cells (5  105 cells/2 mL) induced
apoptosis and were collected by centrifugation at
1000 rpm for 10 min. Supernatants were removed, pellets
were homogenized using 200 ml of medium, and 20 ml of
JC-1 dye was added onto the cells. Cells were then incu-
bated at 37C in 5% CO2 for 30 min and centrifuged at
400 g for 5 min. Supernatants were removed, and 200 ml
of assay buffer was added onto the pellets and vortexed.
This step was repeated once more. Afterwards, all pellets
were resuspended with 320 ml assay buffer and 100 ml from
each was added into the 96-well plate as triplicates. In
healthy nonapoptotic cells, the aggregate red form has ab-
sorption/emission maxima of 560/595 nm, whereas in
apoptotic cells the monomeric green form has absorption/
emission maxima of 485/535 nm. The plate was read at
these wavelengths using a fluorescence Elisa reader
(Thermo Varioskan Spectrum, Finland). The resulting
green/red (485/560) values were calculated to determine
the changes in MMP.RNA Extraction
Total RNA was isolated from A549, NCI-H358, and MRC-
5, and treated with 50 mmol quercitrin for 48 h using High
Pure RNA Isolation Kit (Roche) in accordance with the
manufacturer’s instructions. RNA concentrations were as-
sessed with the NanoDrop (Thermo Scientific) spectropho-
tometer (260/280 nm ratios) and only the samples with an
A260/A280 ratio between 1.9 and 2.1 were considered suit-
able for use.Microarray Hybridization
Illumina Human HT-12v4 beadchip microarrays (contain-
ing 47,000 probes derived from the National Center for
Biotechnology Information Reference Sequence [NCBI]
RefSeq Release 38 [November 7, 2009] and other sour-
ces) (Illumina, Inc., San Diego, CA) were used to assess
global gene expression for each sample. Five hundred
nanograms of total RNA was amplified, converted to
cRNA, fragmented, and then biotin-labeled using the Illu-
mina TotalPrep RNA-amplification kit (Ambion, Life
Technologies, Grand Island, NY). Then, 1.5 mg of labeled
cRNA was hybridized to each array in accordance with
the Illumina whole-genome gene expression direct hy-
bridization assay protocol, after which arrays were
scanned using the Illumina BeadArray Reader. Images
were processed and converted into signal intensities using
the Illumina GenomeStudio software (Illumina, Inc.). The
same software was used to perform hybridization quality
control (QC).
Figure 1. Effects of quercitrin on cell proliferation and cytotoxicity of A549 (AeD), NCI-H358 (BeE), and MRC-5 (CeF) cells. WST-1 and LDH assays
were performed using triplicate samples in three independent experiments. Statistical significance was determined using two-way analysis of variance,
*p ! 0.05, **p !0.01 was considered significant. IC50 value of quercitrin was calculated from cell proliferation plots.
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The signal intensities corresponding to gene expression
levels of individual arrays were background corrected
and imported into text files using the Illumina Genome
Studio. Hierarchical cluster analysis performed on data-
sets to evaluate the ‘‘proximity’’ between the time points.
For data visualization, hierarchical clusters were con-
structed with the statistically significant ( p!0.05) genes.
Computing a p value for each gene assessed the statistical
significance of the differential expression of genes. Genes
were considered differentially expressed when logarith-
mic gene expression ratios in three independent hybrid-
izations were O1.5 or !0.66, i.e., 1.5-fold difference
in expression level, and when the p values were !0.05.
Using the Kyoto Encyclopedia of Genes and Genomes
(KEGG) and Ingenuity Pathway Analysis (IPA; IngenuitySystems, Redwood City, CA), gene ontology and pathway
analyses were performed to consider the biological mean-
ing of differential expression of genes between the data
points.Results
Quercitrin Inhibited Proliferation of A549 and NCI-H358
NSCLC Cell Lines in a Time- and Dose-dependent
Manner
To determine the antiproliferative effects of quercitrin on
A549 and NCI-H358 NSCLC, and MRC-5 normal lung
fibroblast cells as a control line, the cells were incubated
with increasing concentrations of quercitrin for 24, 48,
72 h using WST-1 cell proliferation assay. The results of
these assays showed that there were time- and dose-
Figure 2. Effects of quercitrin on apoptosis-related nucleosomal enrich-
ment factor of A549 (2A), NCI-H358 (2B), cells. The Cell Death detection
plus ELISA were performed using triplicate samples in at least two inde-
pendent experiments. Statistical significance was determined using two-
way analysis of variance, and p !0.05 was considered significant.
Figure 4. Effects of quercitrin on membrane potential in A549 and MRC-
5 cells. Loss of mitochondrial membrane potential in response to
increasing concentrations of quercitrin in A549 and MRC-5 cells. The re-
sults are the means of two independent experiments. p!0.05 was consid-
ered significant.
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lines compared with controls (Figures 1A-1C).
IC50 values of quercitrin for 24, 48 and 72 h were calcu-
lated from both cell proliferation and cytotoxicity plots and
found to be 50 mmol, respectively (Figure 1).Figure 3. Effects of quercitrin on caspase3 activity in A549 and MRC-
5 cells. Changes in caspase-3 enzyme activity in response to increasing
concentrations of quercitrin in A549 and MRC-5 cells. The results are
the means of two independent experiments. p !0.05 was considered
significant.Quercitrin Has Cytotoxic Effects on A549 and NCI-H358
NSCLC Cell Lines in a Time- and Dose-dependent
Manner
To determine the cytotoxic effects of quercitrin on A549
and NCI-H358 NSCLC, and MRC-5 normal lung fibroblast
cells as a control line, the cells were incubated with
increasing concentrations of quercitrin for 24, 48, 72 h us-
ing an LDH assay. The results of these assays showed that
there were time- and dose-dependent increases in cytotox-
icity only in the NSCLC cell lines compared with controls
(Figures 1De1F). IC50 values of quercitrin for 24, 48 and
72 h were calculated from both cell proliferation and cyto-
toxicity plots and found to be 50 mmol, respectively
(Figure 1).Quercitrin Increases Nucleosomal Enrichment Factor in a
Time- and Dose-dependent Manner
To determine the apoptotic effects of quercitrin on A549
and NCI-H358 cells, these cells were incubated with
increasing concentrations of quercitrin for 48 and 72 h,
and changes in nucleosomal enrichment factor (EF) were
analyzed. There were subsequently 4.53- and 5.07-fold in-
creases in EF in response to 48 and 72 h incubation with
50 mmol quercitrin on A549 cells as compared with un-
treated cells (Figure 2A). Also, there were 4.87- and
6.08-fold increases in EF in response to 48 and 72 h incu-
bation with 50 mmol quercitrin on NCI-H358 cells when
compared with untreated cells (Figure 2B).Quercitrin Increases Caspase-3 Enzyme Activity in a
Time- and Dose-dependent Manner
To determine the apoptotic effects of quercitrin on A549
and MRC-5 cells, these cells were incubated with
Figure 5. FITC AnnexinV/PI double staining of A549 (5A) cells NCI-H358 (5B) cells treated with increasing concentrations of quercitrin. Early apoptotic
cells labelled with Annexin-V(þ)/PI (e) and apoptotic cells labelled with Annexin-V(þ)/PI(e) in flow cytometric graphics. The results are the means of two
independent experiments. p !0.05 was considered significant. Cell population graphs shown in Figures 5Be5D.
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in caspase-3 enzyme activities were analyzed. There was a
1.19-fold increase in caspase-3 activity in response to 48 h
incubation with 50 mmol quercitrin on A549 cells when
compared with untreated cells (Figure 3). There was no
change in caspase3 activity of MRC-5 cells under the same
conditions as with A549 cells (Figure 3). The fact that quer-
citrin induced apoptosis in a dose-dependent manner may
be related with caspase-3 activity.
Quercitrin Induces the Loss of Mitochondrial Membrane
Potential in a Time- and Dose-dependent Manner
To assess the loss of MMP, A549 and MRC5 cells were
exposed to 50 mmol quercitrin for 48 h and a JC-1 MMP
assay was performed. The results of this assay revealed that
there was a 1.14-fold increase in the loss of MMP in
response to 50 mmol quercitrin for 48 h A549 cells when
compared with untreated cells (Figure 4). There was no
change for MMP potential of MRC-5 cells under the same
conditions with A549 cells (Figure 4).Quercitrin Causes Modulation of the Cell Membrane
Resulting in the Translocation of PS from the Inner to the
Outer Leaflet in a Time- and Dose-dependent Manner
To confirm the results of caspase-3 activity and loss of
MMP, FITC AnnexinV/PI double staining was performed
in A549 (Figure 5A) and NCI-H358 (Figure 5B) NSCLC
cell lines and MRC-5 normal lung fibroblast cells as a con-
trol line exposed to 50 mmol quercitrin for 48 h. The results
demonstrated that 48 h incubation of A549 and NCI-
H358 cells with 50 mmol quercitrin increased apoptotic cell
death when compared with untreated control group
(Figures 5C and 5D).Changes in Expression Levels of Whole Genome in
Response to Quercitrin
To determine the biologically relevant networks beyond
canonical pathways, pathway analysis was performed
for gene sets using IPA. The networks describe func-
tional relationships between gene products based on
Table 1. Top networka
Genes involved in network Score Network
YACBD6,[ALKBH7,YANAPC15,YC21orf59a,YC2orf49,[C6orf123,[C7orf10,[CEP95,YCOQ3,YCRYZL1,
YCTDSPL2,YDTWD1,[ERI2,YFAHD2A,YFAM216 A,[GOLIM4,YHNF4A,YKIAA0141,[KLHL28,YLSMD1,
YMRPL22,[OGFOD2,YPOC1A,YPRR3a,[RBAK,YRBKS,[RIOK1,YSLC22A18,YSLC25A40,YTMEM208a,
[TMEM242,[ZAN,[ZNF502,[ZFCAN18
34 Cellular development, cell morphology, cellular
function and maintenance
[ADRA2C,YBAI1,YBDKRB1,[CCRL2,[CELSR3,YF2RL2,[FZD4,[GABBR2,[GALR3,Gpcr,[GPR4,[GPR19,
[GPR63,[GPR83,[GPR98a,YGPR110,YGPR126,[GPR128,[GPR173,[GPR174,[GPR137 B,[LPAR3,[LPAR5,
YLPAR6,[MC1R,YNMUR1, [NPBWR1,YNPFFR2,[NPY5R,[OPN1MW/OPN1MW2,YP2RY6,[P2RY11,
[PTGDR2,[UTS2R,[VN1R1
32 Cell-to-cell signaling and interaction, nervous system
development and function, carbohydrate metabolism
[ASB6,[CERS5,YDCUN1D5a,YDDX19 B,YERCC1,YERCC2,[F2RL1,GADD45,[IRF2BP2a,[KEAP1a,[MAT2A,
YMCTS1,YMRPL12,YNKX6-,[P2RX2,[P2RX3,[PIDD,YPOLRMT,[RBM38,[RBM39,YRCHY1,[SAP18,
[SERTAD1,YSF3B1,[SP4,[SPRK2,[SRRM2,[SUGP1,YTFB1M,TIP60,YTMEM160,[U2AF2,YVWA8,YWDR33a,
YWWOX
30 Developmental disorder, hereditary disorder, neurological
disease
YABCC4,[ACBD7,[AHNAK2a,Androgen-AR,[ARa,YCCDC74 A/CCDC748,YCD38,YCD302,YCDH1,YCDKN3,
YCHD2,Ck2,YCRISP1,[FAM3Ca[,FAM50 A,YFDCSP,[GALK2,YGSTP1,[HGF,YKRT81,[MGEA5,[NKXX2-4,
YPATZ1,YPEX16,[POMT2,YPOU5F2,YPTPRU,YRNF14,YSLC39A8,[SLFNL1[SMAD3,YTGIF2,[THSD1,
[ZCCH14,Z[CCHC18
30 Tumor morphology, cell morphology, cellular development
YADK,[AMICA1,[ARAP2,YATG7,YCAMK2Ba,[CASP8,YCOL3A1,[EGR2,[F3,[FAIM,[FASa,[GIMAP6,
YGLIPR1,YGPR56a,YHMGB2,[HN1L,[KDR,[LOC645166,YNUAK2a,[PGA3,[PSD4,[RBM15 B,YSLC16A13,
[SLC7A9,[SMPD1,[SPATA18,[SRD5A3,YTGM2,YTMX1,TNFR/Fas,YTNFRSF1A,YTNFRSF1B,YTP63,
YTSPAN14
29 Lipid metabolism, small molecule biochemistry, cell death
and survival
20s proteasome,[ABCF2,YCCR9,[CYP26B1,[EPAS1,[FAM102 Aa, [FAM103 Aa, YFAM176 A, [FAM43 A,
[FLG,[HAVCR2,[HIST2H2AA3/HIST2H2AA4a,[HMGA2,YIL15a,YINO80 C,[KDM3A,KIR,[mir-196a,
[MYOM2,[NFRKB,[ODC1,[OMA1,YPLGRKT,[POLH,YPSMA6,YPSMA8,YPSMB6,YPSMB9, YSAT1,
[SH2GL2,YSLC16A4a,YSORL1,YTCEA1,YTCEA2
28 Molecular transport, small molecule biochemistry, cellular
development
aLiterature-based clustering of differentially genes using an Ingenuity Pathway Analysis (IPA) after 48 h of 50 mmol quercitrin stimulation in A549 cells. According to IPA, three major pathways emerged:
(I) cell signaling, molecular transport, (II) cellular assembly and organization and (III) cellular development.
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Table 2. Literature-based clustering of differentially genes using an
Ingenuity Pathway Analysis (IPA) after 48 h of 50 mM quercitrin
stimulation in NCI-H358 cellsa
Diseases and disorders p # molecules
Cancer 1,30E-16-3,55E-03 1104
Gastrointestinal disease 1,45E-12-1,43E-03 487
Reproductive system disease 3,95E-08-3,11E-03 378
Respiratory disease 1,15E-07-1,39E-03 247
Endocrine system disorders 2,76E-06-3,11E-03 184
Molecular and cellular functions
Cell death and survival 5,99E-08-3,57E-03 875
Cellular growth and proliferation 1,87E-07-3,53E-03 868
Cell cycle 1,31E-06-3,29E-03 383
Cellular development 3,42E-06-3,53E-03 779
Cell morphology 7,73E-06-3,20E-03 389
aAccording to IPA, two major pathways emerges: (I) cell-to-cell signaling
and interaction, cell-mediated immune response, inflammatory response
and (II) cell response to therapeutics.
452 Cincin et al./ Archives of Medical Research 45 (2014) 445e454known interactions reported in the literature. Results
for the network analysis are displayed in Tables 1e3.
Results for pathway analysis displayed in Figures 6
and 7.Discussion
Quercitrin, which mostly exists in its glycoside form quer-
citrin?, is the most widely distributed flavonoid in nature. It
possesses various potential properties including an antioxi-
dant and anti-inflammatory for cell damage of b-cells; how-
ever, the underlying mechanisms leading to its anticancer
effects are still unknown.
There are limited studies focusing on the anticancer ef-
fects of quercitrin in the literature. Epidemiologic studies
have indicated that dietary flavonoids could present their ef-
fects in oral cancer. Browning et al. examined whether
quercitrin could directly affect cell proliferation using hu-
man oral squamous carcinoma SCC-9 cells. They found
that quercitrin showed no effect with minimal cellular up-
take and no hydrolysis (19). Xu et al. studied the molecular
mechanisms of apoptosis in prostate cancer induced byTable 3. Literature-based clustering of differentially genes using an Ingenuity P
cancer cellsa
Pathway name Differentia
Leukocyte transendothelial
migration
ACTN1,ACTN4,CLDN10,CLDN23,CLDN4,CLD
PRKCB,PTK2B,RAP1A,ROCK1
Adherens junction ACTN1,ACTN4,BAIAP2,CSNK2A1,CSNK2A2,IG
Antigen processing and
presentation
CD74,CTSB,HLA-A,HLA-DQA1,HLA-DRB4,HL
E,HSP90AA1,HSPA1L,HSPA6,HSPA8,IFNA1,IFN
Phosphatidylinositol
signaling system
DGKQ,INPP4A,INPP5D,PIK3C2A,PIK3R1,PLCB
aAccording to IPA, two major pathways emerges: (I) Leukocyte transendotheliaquercitrin and found that quercitrin exerted little effect
and was not effective at inducing apoptosis (20). Ding
et al. examined the effects of quercitrin on tumor promotion
in mouse JB6 cells and quercitrin blocked TPA-induced
neoplastic transformation in JB6 Pþ cells (14). They also
showed that quercitrin stimulated the activation of NF-
E2-related factor (Nrf2) and GST ARE luciferase activity
and that it was able to block DNA damage induced by
UVB (14).
In this study we determined that quercitrin has antipro-
liferative, cytotoxic, and apoptotic effects in NSCLC cell
lines. Zheng et al. showed that quercetin revealed its anti-
cancer effect by induction of apoptotic mechanism on
A549 lung cancer cell lines in time- and dose-dependent
manner in accordance with our results (21). In order to
determine networks and pathways regulated by quercitrin
treatment in NSCLC and lung fibroblast cells, we per-
formed Illumina Human HT-12v4 beadchip microarrays
on A549, NCI-H358, and MRC5 cells. After normalizing
microarray data with Genome Studio, we used IPA soft-
ware (Ingenuity Systems Inc.) to perform pathway ana-
lysis by comparing gene expression values between
50 mmol quercitrin and untreated cells. We performed
biological function analysis by comparing quercitrin
treated and control fold change values and found that can-
cer, cell death, and cellular growth were the most statisti-
cally significant biofunctions among others in both A549
and NCI-H358 cell lines, respectively. After pathway
analysis, we determined that leukocyte transendothelial
migration, cell adhesion, phosphatidylinositol signaling
system and DNA damage pathways were the most statis-
tically significant pathways for both A549 and NCI-
H358 cell lines.
As a result, we found that quercitrin could help to induce
cancer-related pathways and found that cellular develop-
ment and apoptosis were closely related on NSCLC cells.
The results indicated that quercitrin-induced antiprolifera-
tive effect could inhibite cell adhesion pathway, directing
NSCLC cells to migration. We believe that these data will
help to understand molecular mechanisms underlying quer-
citrin apoptotic effects.athway Analysis (IPA) after 48 h of 50 mmol quercitrin stimulation in
lly expressed genes Adjusted p
N8,F11 R,ITGB1,MSN,MYL2,MYL9,OCLN,PIK3R1, 0
F1R,INSR,LEF1,RAC3,SNAI2,SORBS1,SRC,TCF7,WAS 4,30E-14
A-
A6,KIR2DL3,KIR2DL4,KIR2DS5,KIR3DL3,LLRC3,LTA
6,54E-10
2,PLCE1,PRKCB 3,46E-03
l migration and (II) CAM adhesion molecules.
Figure 6. Functional analysis of the top selected genes identified. The network was algorithmically constructed by Ingenuity Pathway Analysis (IPA) soft-
ware on the basis of the functional and biological connectivity of genes. HNF4A in central node generated by the Ingenuity Pathway Analysis (IPA) software
are shown.
Figure 7. DNA Damage Signaling Network. Ingenuity pathway analysis (IPA) software was used to analyze identified genes involved in the DNA Damage
pathway that were differentially expressed in A549, NCI-H358 cells. Genes labeled in red and green were those identified as up- and down-regulated and
other genes were those related to the regulated genes on the basis of the network analysis.
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